Literature DB >> 19474267

Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center.

Tara Babu1, Violeta Rekasius, Jorge P Parada, Paul Schreckenberger, Malliswari Challapalli.   

Abstract

All patients admitted to our tertiary care hospital from 1 December 2007 to 10 June 2008 were screened for methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) nasal colonization, and the isolates were tested for mupirocin susceptibility by using Etest. Mupirocin resistance (MR) was noted to occur in 3.4% of MRSA carriers, and high-level MR was noted to occur in 0.62% of carriers.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19474267      PMCID： PMC2708468          DOI： 10.1128/JCM.01834-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  20 in total

1.  Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains.

Authors:  M Semret; M A Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2001-09       Impact factor: 3.254

2.  Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization.

Authors:  Susan S Huang; Richard Platt
Journal:  Clin Infect Dis       Date:  2003-01-17       Impact factor: 9.079

3.  Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic.

Authors:  P C Fuchs; R N Jones; A L Barry
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

Review 4.  Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent.

Authors:  M W Casewell; R L Hill
Journal:  J Antimicrob Chemother       Date:  1987-01       Impact factor: 5.790

5.  Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment.

Authors:  M A Miller; A Dascal; J Portnoy; J Mendelson
Journal:  Infect Control Hosp Epidemiol       Date:  1996-12       Impact factor: 3.254

6.  Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus.

Authors:  J A Kluytmans; J W Mouton; M F VandenBergh; M J Manders; A P Maat; J H Wagenvoort; M F Michel; H A Verbrugh
Journal:  Infect Control Hosp Epidemiol       Date:  1996-12       Impact factor: 3.254

7.  Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance.

Authors:  A Upton; S Lang; H Heffernan
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

8.  High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases.

Authors:  J Gilbart; C R Perry; B Slocombe
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

9.  Mechanism of mupirocin transport into sensitive and resistant bacteria.

Authors:  J O Capobianco; C C Doran; R C Goldman
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

10.  Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals.

Authors:  Scott K Fridkin; Holly A Hill; Nataliya V Volkova; Jonathan R Edwards; Rachel M Lawton; Robert P Gaynes; John E McGowan
Journal:  Emerg Infect Dis       Date:  2002-07       Impact factor: 6.883
View more
  8 in total

1.  Ozenoxacin: A novel topical antibiotic.

Authors:  Parvathy Santhosh; Mithun Harold Thomas
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jan-Feb       Impact factor: 2.545

2.  2020 American Society for Microbiology Awards Program Honorees in Clinical Microbiology.

Authors:  Erik Munson
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

3.  LTX-109 is a novel agent for nasal decolonization of methicillin-resistant and -sensitive Staphylococcus aureus.

Authors:  Anna C Nilsson; Håkan Janson; Hedda Wold; Anders Fugelli; Karin Andersson; Camilla Håkangård; Pernilla Olsson; Wenche Marie Olsen
Journal:  Antimicrob Agents Chemother       Date:  2014-10-20       Impact factor: 5.191

Review 4.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States.

Authors:  Adriana Cadilla; Michael Z David; Robert S Daum; Susan Boyle-Vavra
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

6.  Pathogen profiling: rapid molecular characterization of Staphylococcus aureus by PCR/electrospray ionization-mass spectrometry and correlation with phenotype.

Authors:  Donna M Wolk; Lawrence B Blyn; Thomas A Hall; Rangarajan Sampath; Raymond Ranken; Cristina Ivy; Rachael Melton; Heather Matthews; Neill White; Feng Li; Vanessa Harpin; David J Ecker; Brandi Limbago; Linda K McDougal; Vicki H Wysocki; Mian Cai; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

7.  In vitro activities of LTX-109, a synthetic antimicrobial peptide, against methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, daptomycin-nonsusceptible, and linezolid-nonsusceptible Staphylococcus aureus.

Authors:  Louis D Saravolatz; Joan Pawlak; Leonard Johnson; Hector Bonilla; Louis D Saravolatz; Mohamad G Fakih; Anders Fugelli; Wenche Marie Olsen
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

8.  Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSA.

Authors:  Sarah R Deeny; Colin J Worby; Olga Tosas Auguet; Ben S Cooper; Jonathan Edgeworth; Barry Cookson; Julie V Robotham
Journal:  J Antimicrob Chemother       Date:  2015-09-03       Impact factor: 5.790
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.